Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Radiation Exposure
Interventions
DRUG

CardioGen-82

CardioGen-82 was not administered as part of this trial but the patients enrolled had to have received CardioGen-82 previously

DRUG

CardioGen-82

Patients do not received CardioGen-82 as part of this study. To be in the study they would have had to receive CardioGen-82 previously.

Trial Locations (1)

08540

Bracco Diagnostics, Inc., Princeton

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY